Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-023127
Filing Date
2020-08-20
Accepted
2020-08-20 20:03:11
Documents
1
Period of Report
2020-08-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3908
  Complete submission text file 0000899243-20-023127.txt   5338
Mailing Address C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET, SUITE 1100 CAMBRIDGE MA 02142
Business Address
Nielsen Jack (Reporting) CIK: 0001602402 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39450 | Film No.: 201121260

Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Issuer) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations